Clinical commissioning of intensity‐modulated proton therapy systems: Report of AAPM Task Group 185
Citations Over TimeTop 10% of 2020 papers
Abstract
Proton therapy is an expanding radiotherapy modality in the United States and worldwide. With the number of proton therapy centers treating patients increasing, so does the need for consistent, high-quality clinical commissioning practices. Clinical commissioning encompasses the entire proton therapy system's multiple components, including the treatment delivery system, the patient positioning system, and the image-guided radiotherapy components. Also included in the commissioning process are the x-ray computed tomography scanner calibration for proton stopping power, the radiotherapy treatment planning system, and corresponding portions of the treatment management system. This commissioning report focuses exclusively on intensity-modulated scanning systems, presenting details of how to perform the commissioning of the proton therapy and ancillary systems, including the required proton beam measurements, treatment planning system dose modeling, and the equipment needed.
Related Papers
- → Concurrent chemo-radiotherapy with proton therapy: reduced toxicity with comparable oncological outcomes vs photon chemo-radiotherapy(2020)6 cited
- → Treatment planning in proton therapy(2011)18 cited
- → TH‐AB‐BRD‐02: Proton Treatment Planning(2015)
- → MO-E-BRCD-01: Proton Treatment Planning Issues(2012)
- → MO‐D‐500‐01: Treatment Planning in Proton Therapy(2013)